Acrolein produced by glioma cells under hypoxia inhibits neutrophil AKT activity and suppresses anti-tumoral activities
- 4 July 2023
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 207, 17-28
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Neutrophil cell surface receptors and their intracellular signal transduction pathwaysInternational Immunopharmacology, 2013
- VEGF-A recruits a proangiogenic MMP-9–delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissueBlood, 2012
- Acrolein Induces Endoplasmic Reticulum Stress and Causes Airspace EnlargementPLOS ONE, 2012
- The Tobacco Smoke Component, Acrolein, Suppresses Innate Macrophage Responses by Direct Alkylation of c-Jun N-Terminal KinaseAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Protein modification by acrolein: Relevance to pathological conditions and inhibition by aldehyde sequestering agentsMolecular Nutrition & Food Research, 2011
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Protein Modification by Acrolein: Formation and Stability of Cysteine AdductsChemical Research in Toxicology, 2009
- Critical role of acrolein in secondary injury following ex vivo spinal cord traumaJournal of Neurochemistry, 2008
- Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and diseaseMolecular Nutrition & Food Research, 2008
- Kinetics and Mechanism of Protein Tyrosine Phosphatase 1B Inactivation by AcroleinChemical Research in Toxicology, 2007